Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

INDUSTRY 10OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 8Breast Neoplasms 7Uterine Cervical Neoplasms 6Uterine Cervical Dysplasia 5Persistent Infection 4Melanoma 4Glioblastoma 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Neuroblastoma 2Lung Neoplasms 2Influenza, Human 2HIV Infections 2Glioma 2Condylomata Acuminata 2Breast Neoplasms, Male 2Wilms Tumor 1Waldenstrom Macroglobulinemia 1Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spondylitis, Ankylosing 1Small Cell Lung Carcinoma 1Rheumatic Diseases 1Recurrence 1Psoriasis 1Prostatic Neoplasms 1Papillomavirus Infections 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasms, Nerve Tissue 1

Interventions

Human Papillomavirus Recombinant Vaccine nonavalent 9Papillomavirus Vaccines 8Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 8Surveys and Questionnaires 6Educational Status 6Blood Specimen Collection 5Vaginal Smears 4Radiotherapy, Intensity-Modulated 4Methods 4Human Papillomavirus DNA Tests 4Early Intervention, Educational 4Cisplatin 4Carboplatin 4Patient Navigation 3Mass Screening 3Taxes 2Standard of Care 2Radiation 2Practice Guidelines as Topic 2Papanicolaou Test 2Paclitaxel 2Motivational Interviewing 2Interviews as Topic 2Electrocoagulation 2Docetaxel 2Cytological Techniques 2Cryotherapy 2Colposcopy 2utomilumab 1toripalimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Papillomavirus Infections × Vaccines × Clear all
NCT01512784 2012-01-19

Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults

University of Milan

Phase 3 Unknown
100 enrolled

HIV Infections, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡